본문 바로가기
KERD
논문KCI 등재

비만환아에서 복약기간에 따른 비만탕의 치료효과 비교연구

Comparisons of Effects of Biman-tang according to Administration Period in Childhood Obesity

1

조회

0

다운로드

4

인용

0

참고문헌

키워드

주제분류한의학

초록

Objectives The purpose of this study is to investigate the safety and effect of Biman-tang (BMT) on two different administration periods in the treatment of childhood overweight and obesity. Methods In retrospective study, 39 overweight and obese (85th percentile ≤ Body Mass Index (BMI)) children were treated with BMT from January 2006 to April 2013 at Korean Medical Clinic in Suwon, Korea. The primary outcomes were the changes in BMI and Obesity Index (OI) from baseline to the treatment groups. Secondary outcomes included the changes in height, weight and safety of the medicine. Comparisons of BMI, OI, height and weight between the short-period (SP) treatment group and the long-period (LP) treatment group were done by using ANCOVA. Results The change of the mean of BMI (-0.5 ± 0.6 kg/m2 vs -1.4 ± 0.8 kg/m2, respectively; p=0.003) and OI (-3.6 ± 3.9% vs -9.7 ± 4.7%, respectively; p<0.001) showed significant reduction both in SP (n=16) and LP treatment group (n=23). The mean height showed no significant difference in both groups. The mean weight of LP treatment group showed significant reduction compared to SP treatment group (-0.2 ± 1.3 kg vs -1.6 ± 1.6 kg, respectively; p=0.006). Most of the children were compliant to the medication and no serious adverse events were found in two groups. Conclusions These findings emphasize that BMT is effective in the treatment of childhood obesity and it requires at least 45 days of treatment for the best result.

Abstract

Objectives The purpose of this study is to investigate the safety and effect of Biman-tang (BMT) on two different administration periods in the treatment of childhood overweight and obesity. Methods In retrospective study, 39 overweight and obese (85th percentile ≤ Body Mass Index (BMI)) children were treated with BMT from January 2006 to April 2013 at Korean Medical Clinic in Suwon, Korea. The primary outcomes were the changes in BMI and Obesity Index (OI) from baseline to the treatment groups. Secondary outcomes included the changes in height, weight and safety of the medicine. Comparisons of BMI, OI, height and weight between the short-period (SP) treatment group and the long-period (LP) treatment group were done by using ANCOVA. Results The change of the mean of BMI (-0.5 ± 0.6 kg/m2 vs -1.4 ± 0.8 kg/m2, respectively; p=0.003) and OI (-3.6 ± 3.9% vs -9.7 ± 4.7%, respectively; p<0.001) showed significant reduction both in SP (n=16) and LP treatment group (n=23). The mean height showed no significant difference in both groups. The mean weight of LP treatment group showed significant reduction compared to SP treatment group (-0.2 ± 1.3 kg vs -1.6 ± 1.6 kg, respectively; p=0.006). Most of the children were compliant to the medication and no serious adverse events were found in two groups. Conclusions These findings emphasize that BMT is effective in the treatment of childhood obesity and it requires at least 45 days of treatment for the best result.

참고문헌 (43)

  1. Christie D, "Assessing the efficacy of the Healthy Eating and Lifestyle Programme(HELP)compared with enhanced standard care of the obese adolescent in the community : study protocol for a randomized controlled trial", Trials, 12, pp.242~ (2011)
  2. Giordano U, "Cardiovascular hemodynamics : relationships with insulin resistance in obese children", Pediatr Cardiol, 24, pp.548~552 (2003)
  3. Schwimmer JB, "Health-related quality of life of severely obese children and adolescents", JAMA, 289, pp.1813~1819 (2003)
  4. Srinivasan SR, "Predictability of childhood adiposity and insulin for developing insulin resistance syndrome(syndrome X)in young adulthood : the Bogalusa Heart Study", Diabetes, 51, pp.204~209 (2002)
  5. Williams J, "Health-related quality of life of overweight and obese children", JAMA, 293, pp.70~76 (2005)
  6. Griffiths LJ, "Self-esteem and quality of life in obese children and adolescents : a systematic review", Int J Pediatr Obes, 5, pp.282~304 (2010)
  7. Ferraro KF, "Cumulative Disadvantage and Health: Long-Term Consequences of Obesity?", Am Sociol Rev, 68, pp.707~729 (2003)
  8. Caterson I, "Early response to sibutramine in patients not meeting current label criteria : preliminary analysis of SCOUT lead-in period", Obesity (Silver Spring), 18, pp.987~994 (2010)
  9. Chanoine JP, "Early weight loss and outcome at one year in obese adolescents treated with orlistat or placebo", Int J Pediatr Obes, 6, pp.95~101 (2011)
  10. Chanoine JP, "Effect of orlistat on weight and body composition in obese adolescents : a randomized controlled trial", JAMA, 293, pp.2873~2883 (2005)
  11. Danielsson P, "Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes", J Clin Endocrinol Metab, 92, pp.4101~4106 (2007)
  12. Aronne LJ, "Enhanced weight loss following coadministration of pramlintide with sibutramine or phentermine in a multicenter trial", Obesity (Silver Spring), 18, pp.1739~1746 (2010)
  13. 이동형, "消肥飮이 비만아의 체질량지수와 비만도 감소에 미치는 영향", 대한한방소아과학회지, 23(1), pp.195~203 (2009), 대한한방소아과학회
  14. 박민정, "과체중・비만인 결손가정 소아청소년에 대한 한방 비만 치료 프로그램 적용 사례", 한방재활의학과학회지, 22(4), pp.147~156 (2012), 한방재활의학과학회
  15. You JH, "Clinical trial of herbal formula on weight loss in obese korean children", Am J Chin Med, 33(5), pp.713~722 (2006)
  16. Jung JH, "Analysis of in-hospital child obese patients in Obesity clinic", J Pediatr Korean Med, 11(1), pp.149~158 (1997)
  17. Dept. of Sasang Constitutional Medicine, "All colleges of oriental med, In Sasang Constitutional Medicine", pp.487~ (2004), Jipmundang
  18. Jang YJ, "Effect of Taeyeumjowee-Tang and electroacupuncture combined-therapy on obese patients", Journal of society of Korean medicine for obesity research, 1(1), pp.77~83 (2001)
  19. Lee SH, "Effects of Taeyeumjowuitang (Taiyintiaowei-tang) on the correlation between heart rate variability and obesity parameters", J Oriental Rehab Med, 15(4), pp.47~54 (2005)
  20. 서남준, "加味太陰調胃湯 전탕액을 활용한 비만 환자에 대한 임상 연구", 동의생리병리학회지, 22(2), pp.446~452 (2008), 대한동의병리학회
  21. 김혜주, "태음조위탕의 적용이 태음인 비만여대생의 신체조성, 혈청지질농도 및 혈중 항산화 효소에 미치는 효과", 사상체질의학회지, 23(3), pp.391~401 (2011), 사상체질의학회
  22. The Committee for Public Health Statistics, "2007 Korean National Growth Charts" (2007)
  23. "Terminology Criteria for Adverse Events (CTCAE) version 4.0"[URL]
  24. Moon SH, "The effects of proliferation and differentiation on adipocyte 3T3-L1 by herbs and herbal prescriptions of Soeumin and Soyangin", Kyunghee University college of oriental medicine, 21(1), pp.453~477 (1997)
  25. Cho EM, "Effect of Fangfengtongsheng-san on obese patients", Journal of society of Korean medicine for obesity research, 1(1), pp.57~62 (2001)
  26. Lee SY, "Effects of Ondamtang, samulansintang and Shihosogansan water extract on the obesity and stress", J of Oriental Neuropsychiatry, 3(1), pp.25~45 (1992)
  27. Lim DW, "Anti-obesity effect of HT048, a herbal combination, in high fat diet-induced obese rats", Molecules, 17(12), pp.14765~14777 (2012)
  28. Kwon MW, "The clinical study of obese patient treated by Kamijowisengchungtang & Acupunture", J Korean Orient Pediatr, 15(2), pp.43~51 (2001)
  29. 이윤재, "과체중·비만 소아에 대한 한방비만치료프로그램 효과", 한방비만학회지, 9(1), pp.45~51 (2009), 한방비만학회
  30. 조유정, "과체중인 소아에 있어서 아이라진 복용의 효과", 한방비만학회지, 10(2), pp.17~25 (2010), 한방비만학회
  31. Haller CA, "Adverse carduivascular and central nervous system events associated with dietary supplements containing ephedra alkaloids", N Engl J Med, 343(25), pp.1833~1838 (2000)
  32. Song MY, "The safety guidelines for use of Ma-huang in obesity treatment", Journal of society of Korean medicine for obesity research, 6(2), pp.17~27 (2006)
  33. Kim HJ, "A clinical practice guideline for Ma-huang (Ephedra sinica) prescription in obesity", Journal of society of Korean medicine for obesity research, 7(2), pp.27~37 (2007)
  34. Song YK, "Clinical application of Ma Huang in the obesity treatment", Journal of society of Korean medicine for obesity research, 7(1), pp.1~7 (2007)
  35. 형례창, "마황용량에 따른 이상반응에 관한 예비연구:무작위배정이중맹검시험", 대한한방내과학회지, 27(1), pp.188~196 (2006), 대한한방내과학회
  36. 양동혁, "太陰調胃湯과 太陰調胃培麻黃湯이 비만 흰쥐에 미치는 영향", 대한본초학회지, 25(3), pp.103~109 (2010), 대한본초학회
  37. Lisón JF, "Exercise intervention in childhood obesity : a randomized controlled trial comparing hospital-versus home-based groups", Acad Pediatr, 12, pp.319~325 (2012)
  38. de Niet J, "Short Message Service Reduces Dropout in Childhood Obesity Treatment : A Randomized Controlled Trial", Health Psychol, 31, pp.797~805 (2012)
  39. Kelishadi R, "Can a trial of motivational lifestyle counseling be effective for controlling childhood obesity and the associated cardio metabolic risk factors?", Pediatr Neonatol, 53, pp.90~97 (2012)
  40. Koncsos P, "Favorable effect of short-term lifestyle intervention on human paraoxonase-1 activity and adipokine levels in childhood obesity", J Am Coll Nutr, 30, pp.333~339 (2011)
  41. Waters E, "Interventions for preventing obesity in children", Cochrane Database Syst Rev, pp.CD001871~ (2011)
  42. West F, "Randomised clinical trial of a family-based lifestyle intervention for childhood obesity involving parents as the exclusive agents of change", Behav Res Ther, 48, pp.1170~1179 (2010)
  43. Freemark M, "Pharmacotherapy of childhood obesity : an evidence-based, conceptual approach", Diabetes Care, 30, pp.395~402 (2007)

관련 논문AI추천

이 간행물의 다른 논문 (11건)